Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability

Expert Opinion on Pharmacotherapy
Jonjo MillerRohit Shankar

Abstract

ADHD causes significant distress and functional impairment in multiple domains of daily life. Therefore, diagnosis and treatment are important to improve the quality of life of people. The pharmacotherapy for ADHD is well established but needs systematic evaluation in Intellectual Disability (ID) populations. This paper reviews the ADHD pharmacological treatment in people with ID using the PRISMA guidance for scoping reviews to help identify the nature and strength of evidence. In the last 20 years, seven randomized controlled trials have evaluated pharmacotherapies for ADHD in people with ID; five looking at methylphenidate. Generally, studies were underpowered; all but two had less than 25 participants. Of the two larger trials one was single blinded and therefore open to bias. Only two used a parallel-group method, the remainder were mostly short crossover trials; not ideal when measuring behavioral and psychological parameters which are long standing. The remaining evidence is made up of observational studies. Methylphenidate and atomoxetine, particularly at higher doses, have shown clear benefits in people with ID. Most people with ID tolerated ADHD medications well. Benefits were seen in behavioral and/or cognitive domain...Continue Reading

References

Jun 1, 1978·Journal of Abnormal Child Psychology·C H GoyetteR F Ulrich
Sep 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·M G AmanS N Merry
Mar 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·M G AmanS N Merry
May 1, 1988·American Journal of Medical Genetics·R J HagermanM D Wittenberger
Jan 1, 1982·Applied Research in Mental Retardation·M G Aman, N N Singh
Jan 1, 1995·Archives of Pediatrics & Adolescent Medicine·G P ConnersD W Ochsenschlager
Jul 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·M G AmanL E Arnold
Jan 1, 1996·Research in Developmental Disabilities·M G AmanD Hammer
Aug 13, 1998·Journal of Abnormal Child Psychology·C K ConnersJ N Epstein
May 5, 2000·Developmental Medicine and Child Neurology·P Strømme, T H Diseth
Jan 25, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Deborah A PearsonLynne A Cleveland
Feb 1, 2003·Journal of Intellectual Disability Research : JIDR·E Emerson
Jun 14, 2003·Journal of Child and Adolescent Psychopharmacology·Michael G AmanL Eugene Arnold
May 29, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Deborah A PearsonLynne A Cleveland
May 29, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Deborah A PearsonLynne A Cleveland
Aug 21, 2004·Journal of Child and Adolescent Psychopharmacology·David J PoseyChristopher J McDougle
Feb 18, 2005·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Roger JouAntonio Hardan
May 25, 2005·Journal of Child and Adolescent Psychopharmacology·Roger J JouAntonio Y Hardan
Jul 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Alceu Gomes Correia FilhoLuis Augusto Rohde
Jan 2, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Sally-Ann CooperLinda Allan
Apr 3, 2007·European Archives of Psychiatry and Clinical Neuroscience·Christian P JacobKlaus-Peter Lesch
Jun 17, 2008·Journal of Developmental and Behavioral Pediatrics : JDBP·Benjamin L HandenAntonio Y Hardan
Feb 23, 2010·International Journal of Surgery·David MoherUNKNOWN PRISMA Group
Oct 12, 2010·Pediatric Neurology·Alberto Fernández-JaénMaría del Rosario Campos Díaz
Jan 18, 2011·Research in Developmental Disabilities·Pallab K MaulikShekhar Saxena
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Xavier CastellsMiguel Casas
Nov 5, 2011·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Tamar GreenDoron Gothelf
Dec 14, 2011·Journal of Child and Adolescent Psychopharmacology·Tamar GreenDoron Gothelf
Nov 23, 2012·The New England Journal of Medicine·Paul LichtensteinHenrik Larsson
May 11, 2016·JAMA : the Journal of the American Medical Association·Eugenia ChanPaul G Hammerness
May 27, 2016·Journal of Child and Adolescent Psychopharmacology·Ayse KilincaslanNahit Motavalli Mukaddes
Aug 21, 2018·Irish Journal of Psychological Medicine·Bhathika Perera

❮ Previous
Next ❯

Citations

Oct 26, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Geon Ho Bahn, Kyunghoon Seo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.